It is critical that data produced by research facilities can be trusted. This importance has been highlighted in recent publications by pharma industry scientists that analysed reproducibility of results in academic laboratories.
In 2011, Bayer HealthCare reported that for 67 oncology, women's health and cardiovascular projects, only 21% of the published data was supported by in-house data (Prinz F et al , Nat Rev Drug Discov 10:p 712).
Similarly, scientists at Amgen tried to reproduce published preclinical studies. Of 53 papers describing innovative cancer therapeutics, scientific findings were confirmed in only 6 (11%) cases (C. Glenn Begley and Lee Ellis , Nature 483; pp 531533).
Therapeutic Innovation Australia believes that this issue can be partially addressed through use of independent quality accredited laboratories. These laboratories bring additional scientific rigour to studies providing access to high-end technologies and specialist technical expertise. iQDOCs is a crucial part of this strategy, providing a no-cost source of documents to accelerate the process of accreditation or licencing.
Assisting laboratories to efficiently develop and implement Quality Systems documentation will ensure that their products, services and/or results are produced using a standardised methodology that can consistently meet the agreed specifications in order to satisfy the stated or implied need. This will inherently improve the reproducibility of results and ultimately lead to quality outcomes in research and the clinic.
|New ISO standard for urban resilience in development|
|Urbanization is increasing, placing pressure on resources and infrastructure like never before. There’s no stemming the tide, so city leaders need to build resilience in order to cope. Work on a new International...||Read More...|
Receive the latest news and information on iQDOCs